SBI Healthcare Opportunities Fund - Regular Plan -Growth

(Erstwhile SBI Pharma - Regular Plan -Growth)

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 14-07-1999
Asset Class: Equity
Benchmark: BSE Healthcare TRI
Expense Ratio: 1.95% As on (28-02-2025)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 3,521.93 Cr As on (31-01-2025)
Turn over: 29
NAV as on 10-03-2025

393.1516

-4.11 (-1.0456%)

CAGR Since Inception

15.37%

BSE Healthcare TRI 14.66%

PERFORMANCE of SBI Healthcare Opportunities Fund - Regular Plan -Growth

Scheme Performance (%) Data as on - 10-03-2025

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
SBI Healthcare Opportunities Fund - Regular Plan -Growth 16.27 22.34 25.8 11.48 15.37
Benchmark - - - - -
Equity: Sectoral-Pharma and Healthcare 12.43 18.09 24.05 11.62 14.95

Yearly Performance (%)

Nav Movement

Fund Managers

Tanmaya Desai, Pradeep Kesavan

Investment Objective

The scheme seeks maximum growth opportunities through investments in Pharma stocks.

RETURNS CALCULATOR for SBI Healthcare Opportunities Fund - Regular Plan -Growth

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of SBI Healthcare Opportunities Fund - Regular Plan -Growth

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14.02 0.98 6.05 0.8 - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of SBI Healthcare Opportunities Fund - Regular Plan -Growth

Period
Data as on - 10-03-2025
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 16.27 35.41 22.34 25.8 11.48
HDFC Pharma and Healthcare Fund - Growth Option 04-10-2023 23.43 0.0 0.0 0.0 0.0
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth 06-02-2024 22.64 0.0 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 15.45 38.03 21.9 27.41 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 15.39 34.27 18.43 24.39 10.22
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 14.43 31.13 14.66 19.94 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 11.43 32.95 19.8 25.3 0.0
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 11.25 31.69 15.94 24.6 0.0
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 11.23 29.88 16.94 0.0 0.0
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 9.05 32.42 17.37 23.57 0.0

PORTFOLIO ANALYSIS of SBI Healthcare Opportunities Fund - Regular Plan -Growth

Asset Allocation (%)